<doc>
<docno>
88000001
</docno>
internate
<title>
bind
acetaldehyde
active
site
ribonuclease
alteration
catalytic
activiti
effect
phosphate
</title>
<abstract>
ribonuclease
react
[1-13c,1,2-14c]
acetaldehyde
sodium
cyanoborohydride
presence
absence
0.2
phosphate
hour
incubation
degree
(ph
7.4)
stable
acetaldehyde-rnase
adduct
form
extent
formation
similar
presence
phosphate
total
amount
covalent
bind
comparable
absence
presence
phosphate
active
site
ligand
prevent
inhibition
enzymatic
activiti
absence
protective
action
phosphate
diminish
progressive
ethylation
rnase
indicat
reversible
association
phosphate
active
site
lysyl
residue
overcome
irreversible
proces
reductive
ethylation
modifi
rnase
analys
13c
proton
decoupl
nmr
spectroscopi
peak
aris
covalent
bind
enrich
acetaldehyde
free
amino
group
absence
phosphate
nh2-terminal
alpha
amino
group
47.3
ppm
bulk
ethylation
epsilon
amino
group
nonessential
lysyl
residue
43.0
ppm
epsilon
amino
group
lysine-41
active
site
47.4
ppm
spectrum
rnase
ethylat
presence
phosphate
peak
47.4
ppm
absent
rnase
selectiveli
premethylat
presence
phosphate
block
active
site
lysyl
residue
ethylat
absence
signal
43.0
ppm
greatli
diminish
aris
active
site
lysyl
residue
47.4
ppm
enhanc
result
phosphate
specificalli
protect
active
site
lysine
reaction
acetaldehyde
modification
lysine
acetaldehyde
adduct
formation
result
inhibition
catalytic
activiti
</abstract>
</doc>
<doc>
<docno>
88000002
</docno>
<title>
reduction
breath
ethanol
reading
normal
male
volunteer
mouth
rins
water
differ
temperature
</title>
<abstract>
blood
ethanol
concentration
measur
sequentialli
period
hour
lion
ae-d2
alcolmeter
12
healthi
male
subject
oral
ethanol
0.5
g/kg
bodi
wt
reading
rins
mouth
water
vary
temperature
mouth
rins
result
reduction
alcolmeter
reading
water
temperature
test
magnitude
reduction
greater
rins
water
lower
temperature
effect
occur
rins
cool
mouth
dilute
retain
saliva
find
account
breath
analysi
estimate
blood
ethanol
concentration
experimental
situation
</abstract>
</doc>
<doc>
<docno>88000003
</docno>
<title>
blockade
opioid
receptor
influence
development
ethanol
dependence?
</title>
<abstract>
test
opioid
antagonist
naloxone
(2
mg/kg)
naltrexone
(2
mg/kg)
diprenorphine
(0.2
mg/kg)
agonist
morphine
(4-8
mg/kg)
subcutaneousli
(10
min
ethanol
days)
modifi
ethanol
withdrawal
syndrome
(audiogenic
seizures)
chronic
ethanol
intoxication
rat
found
naloxone
naltrexone
diprenorphine
modifi
ethanol
withdrawal
syndrome
finding
rule
possibiliti
biochemical
link
action
ethanol
opiate
level
opioid
receptor
</abstract>
</doc>
<doc>
<docno>88000006
</docno>
<title>
drinkwatchers--description
subject
evaluation
laboratori
marker
heavi
drink
</title>
<abstract>
clinical
examination
measurement
mcv
ggt
carri
124
self-referr
'healthy'
drinkwatcher
consum
80
alcohol/dai
year
majoriti
(66.1%)
social
claes
iii
sixty-three
subject
(54.1%)
rais
mcv
ggt
hepatomegali
rais
mcv
significantli
occur
men
forty-five
subject
(36.3%)
enlarg
liver
17
normal
mcv
ggt
studi
show
mcv
ggt
poor
screen
test
excessive
alcohol
consumption
'healthy'
subject
mcv
appear
sensitive
women
ggt
men
test
adequate
substitute
careful
histori
full
clinical
examination
</abstract>
</doc>
<doc>
<docno>88000007
</docno>
<title>
platelet
affiniti
serotonin
increas
alcoholic
alcoholic
biological
marker
dependence?
</title>
<abstract>
kinetic
3h
serotonin
platelet
uptake
studi
alcoholic
alcoholic
difference
found
alcohol-preferr
non-preferr
rat
reproduc
man
group
patient
studi
10
dependent
alcoholic
admission
treatment
10
dependent
alcoholic
20
day
treatment
dependent
alcoholic
abstinent
1-11
year
control
non-alcoholic
match
age
sex
km
3h
serotonin
uptake
platelet
lower
patient
group
compar
15
control
phenomenon
congenital
induc
previou
excessive
intake
alcohol
increas
platelet
affiniti
serotonin
absence
cirrhosi
liver
and/or
depression
marker
alcohol
dependence
enabl
therapeutic
effort
focuss
patient
</abstract>
</doc>
